PMID: 8946311Jan 1, 1996Paper

Cost effectiveness of screening for primary open angle glaucoma

Journal of Medical Screening
J F BoivinC Archer

Abstract

To determine the cost effectiveness of screening for glaucoma. Information on treatment efficacy, diagnostic methods, epidemiological characteristics of glaucoma, and costs were determined from the literature, from administrative databases, and from experts. Scenarios with different screening frequency, age, participation in screening, compliance with treatment, treatment efficacy, and diagnostic tests were examined. The initial scenario comprised three-yearly screening of subjects aged 40-79 by funduscopy and tonometry, followed by perimetry when abnormalities were discovered. The assumption of levels of participation in screening and of compliance with treatment of 75%, and treatment efficacy of 50% resulted in a cost of $C100,000 per year of blindness prevented. A scenario in which screening was restricted to subjects aged 65-79, with the same input variables, would prevent 81% of the cases of blindness prevented with scenario 1, at a cost of $C42,000 per year of blindness prevented. Screening with tonometry only as the initial diagnostic test in subjects aged 65-79 would result in a cost of $C36,000 per year of blindness prevented, but would only prevent 59% of the cases prevented with scenario 1. There is as yet no proof t...Continue Reading

References

Apr 1, 1979·American Journal of Ophthalmology·H A Quigley, A E Maumenee
Jun 1, 1978·Acta Ophthalmologica·P N SørensenK Nørskov
Aug 1, 1977·Archives of Ophthalmology·E B WernerM Schulzer
Jul 1, 1975·American Journal of Ophthalmology·R Hiller, H A Kahn
Oct 1, 1992·Ophthalmology·B E KleinM J Menage
Mar 1, 1991·Ophthalmology·M SchulzerG R Douglas
Nov 1, 1983·Survey of Ophthalmology·L K GottliebS G Pauker
Nov 1, 1980·American Journal of Epidemiology·J Freeman, G B Hutchison
Mar 1, 1982·Ophthalmology·W M Hart, B Becker
May 1, 1981·American Journal of Epidemiology·M C LeskeM Podgor
Jun 2, 1994·The New England Journal of Medicine·H C Sox
Apr 15, 1993·The New England Journal of Medicine·H A Quigley

❮ Previous
Next ❯

Citations

Dec 17, 2002·Journal of Glaucoma·Gisela Kobelt
Feb 16, 2007·Current Opinion in Ophthalmology·Amish Doshi, Kuldev Singh
Mar 13, 2003·Acta Ophthalmologica Scandinavica·A TuulonenM-L Vuori
Dec 4, 2003·Journal of Glaucoma·Michael IskedjianDavid Covert
Apr 17, 2008·Journal of Glaucoma·Rodolfo HernándezUNKNOWN OAG Screening Project Group
Jul 26, 2006·Journal of Cataract and Refractive Surgery·Steve A Arshinoff, Sylvia H Chen
Apr 4, 2007·PharmacoEconomics·Jordana K SchmierMechelle L Jones
Apr 7, 2021·American Journal of Ophthalmology·Johan AspbergBoel Bengtsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the Virchow-Pirquet Medical Society
Y Kahanowicz
The British Journal of Ophthalmology
S Lin
Fukuoka igaku zasshi = Hukuoka acta medica
H Inomata
© 2021 Meta ULC. All rights reserved